Thermo Fisher Scientific, the world leader in serving science, introduced the Thermo Scientific Orbitrap Isora Mass Spectrometer and Orbitrap Isora Pro M...
OmicsBank, a clinical data infrastructure company connecting fragmented hospital data for drug development and healthcare AI, announced $2.25 million in ...
Vector Science and Therapeutics Corp. ("Vector" or the "Company") is pleased to announce that the Company has entered into an investo...
Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, announced that t...
Lexicon Pharmaceuticals, Inc. announced that it has earned a third $10 million milestone payment in 2026 from Novo Nordisk A/S following the achiev...
Announcing expansion of capabilities to provide customers with a broader range of DNA synthesis solutions, allowing IDT to complement and extend ...
Milestone® Pharmaceuticals Inc. , a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medi...
MaxCyte, Inc. (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development ...
Ecopipam (EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designation NDA acceptance is supported by po...
GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the company Approval provides a long-awaited first-ever option to redu...
Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, announced the continued advancement of its AI ecosystem – ...
The U.S. Food and Drug Administration issued a discussion paper on considerations for the regulation of generative artificial intelligence (GenAI)-enable...
Cellution Biologics Inc. (“Cellution Biologics” or the “Company”), a biologics company focused on developing, manufacturing and c...
- Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooli...
© 2026 Biopharma Boardroom. All Rights Reserved.
